SOCS2 is dispensable for BCR/ABL1-induced chronic myeloid leukemia-like disease and for normal hematopoietic stem cell function

Authors
Publication date
1 January 2012
Publisher

Abstract

C1 - Journal Articles Referee

    Similar works

    Full text

    thumbnail-image

    Available Versions

    University of Melbourne Institutional Repository

    redirect
    oaioai:jupiter.its.unimelb.edu.au...
    Last time updated on 06/01/2019